Unternehmen auf Beobachtungsliste setzen
Eckert & Ziegler Strahlen- und Medizintechnik AG
ISIN: DE0005659700
WKN: 565970
Über
Snapshot Unternehmen
Neu: Benachrichtigung aktivieren
Aktuelle Nachrichten per Alarm empfangem
Neu: KI-Factsheet

Coming soon: Zusammenfassung der Unternehmensnachricht durch KI/p>

Eckert & Ziegler Strahlen- und Medizintechnik AG · ISIN: DE0005659700 · Newswire (adhoc)
Land: Deutschland · Primärmarkt: Deutschland · EQS NID: 1183796
12 April 2021 21:12PM

Eckert & Ziegler Receives Technetium Generator Licenses for Brazil


DGAP-Ad-hoc: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Strategic Company Decision/Miscellaneous
Eckert & Ziegler Receives Technetium Generator Licenses for Brazil

12-Apr-2021 / 21:12 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Sao Paulo, 12 April 2021 - The Brazilian regulator ANVISA has provided Eckert & Ziegler Brasil Comercial Ltda., a fully owned subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX), with a license to import and distribute technetium generators. This is the second license ever given to an organization in Brazil, and only the first one for a private company. Technetium generators are a core component for a nuclear imaging procedure called SPECT, which is used for the detection of medical abnormalities. In Brazil, the SPECT market has a volume of about 100 mm Euro annually. Eckert & Ziegler already services about 500 hospitals and clinics in this country with medical devices and radioisotopes, and hopes to start shipping SPECT products in the third quarter of 2021.

Contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com


Information and Explanation of the Issuer to this News:

Claudia Goulart, CEO of Eckert & Ziegler Brasil, commented: 'We are very excited that Eckert & Ziegler has now been given the opportunity to service the Brazilian nuclear medicine community with SPECT products. It compliments perfectly our existing portfolio of radiopharmaceuticals, among them Lu-177 and O-18, and the services we provide for international pharmaceutical companies'.


12-Apr-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: +49 30 941084-138
Fax: +49 30 941084-112
E-mail: karolin.riehle@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1183796

 
End of Announcement DGAP News Service

1183796  12-Apr-2021 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1183796&application_name=news&site_id=boersengefluester_html






Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency · Reliability · Credibility
Information regarding Product Information
Sonntag, 22.12.2024, Kalenderwoche (KW) 51, 357. Tag des Jahres, 9 Tage verbleibend bis EoY.